We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$68.1M
AUM Growth
+$7.62M
Cap. Flow
+$5.55M
Cap. Flow %
8.16%
Top 10 Hldgs %
77.61%
Holding
35
New
13
Increased
4
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$2.54M
2
ASRT
Assertio
ASRT
+$2.32M
3
PFE icon
Pfizer
PFE
+$753K
4
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
+$701K
5
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$515K

Top Sells

Rank Stock Value
1
TWM icon
ProShares UltraShort Russell2000
TWM
+$1.14M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$443K

Sector Composition

Rank Sector Weight
1 Healthcare 70.16%
2 Miscellaneous 29.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
1
ANI Pharmaceuticals
ANIP
$1.69B
$13.3M 19.53%
395,000
+75,000
+23% +$2.54M
AMRI
2
DELISTED
Albany Molecular Research Inc
AMRI
$6.15M 9.04%
402,400
– –
PFE icon
3
Pfizer
PFE
$160B
$5.19M 7.62%
184,450
+26,350
+17% +$753K
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$5.14M 7.55%
+25,000
New +$4.88M
ASRT
5
DELISTED
Assertio
ASRT
$4.88M 7.16%
5,833
+2,500
+75% +$2.32M
DGX icon
6
Quest Diagnostics
DGX
$27B
$4.73M 6.95%
66,208
– –
AORT icon
7
Artivion
AORT
$1.3B
$4.3M 6.32%
400,000
+30,000
+8% +$305K
QLTI
8
DELISTED
QLT Inc
QLTI
$4.29M 6.31%
2,157,200
– –
AGN
9
DELISTED
Allergan plc
AGN
$2.68M 3.94%
10,000
– –
BIS icon
10
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
$2.18M 3.2%
+6,250
New +$2.17M
GSK icon
11
CALL
GSK
GSK
$101B
$2.03M 2.98%
40,000
– –
EGRX
12
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.02M 2.97%
+50,000
New +$3.17M
TWM icon
13
CALL
ProShares UltraShort Russell2000
TWM
$44M
$1.94M 2.85%
2,500
– –
ASRT
14
CALL
DELISTED
Assertio
ASRT
$1.39M 2.05%
+1,667
New +$1.55M
TWM icon
15
ProShares UltraShort Russell2000
TWM
$44M
$969K 1.42%
1,250
-1,250
-50% -$1.14M
LCI
16
CALL
DELISTED
Lannett Company, Inc.
LCI
$897K 1.32%
+12,500
New +$1.32M
AMRI
17
CALL
DELISTED
Albany Molecular Research Inc
AMRI
$765K 1.12%
+50,000
New +$784K
CYTK icon
18
Cytokinetics
CYTK
$10.8B
$705K 1.04%
100,000
– –
ARLZ
19
CALL
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$621K 0.91%
+175,000
New +$902K
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$609K 0.89%
+50,000
New +$701K
ACAD icon
21
PUT
Acadia Pharmaceuticals
ACAD
$5.12B
$559K 0.82%
+20,000
New +$436K
AORT icon
22
CALL
Artivion
AORT
$1.3B
$538K 0.79%
+50,000
New +$508K
SGNT
23
CALL
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$426K 0.63%
+35,000
New +$491K
FCSC
24
DELISTED
Fibrocell Science Inc.
FCSC
$369K 0.54%
9,851
– –
ARLZ
25
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$355K 0.52%
+100,000
New +$515K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Healthcare Value Capital held 35 positions worth $68.1M, up 13% from $60.5M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Healthcare Value Capital deployed $5.55M of net new capital in Q1 2016, opening 13 new positions and adding to 4 existing holdings. Its largest new stake was SAGENT PHARMACEUTICALS INC COM STK (DE): 50,000 shares worth $609K.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 85% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was ProShares UltraShort Russell2000, an estimated $1.14M trimmed.

  • Healthcare Value Capital's largest Q1 2016 buy was SAGENT PHARMACEUTICALS INC COM STK (DE): 50,000 shares worth $609K.
  • Healthcare Value Capital added most to ANI Pharmaceuticals in Q1 2016, an estimated $2.54M increase.
  • Healthcare Value Capital's biggest Q1 2016 reduction was ProShares UltraShort Russell2000, cutting an estimated $1.14M.
  • Healthcare Value Capital fully exited Pernix Therapeutics Holdings, Inc. in Q1 2016, selling an estimated $443K.
  • Healthcare Value Capital's ten largest holdings make up 78% of its $68.1M portfolio in Q1 2016.
  • Healthcare Value Capital opened 13 new positions and closed 4 in Q1 2016.
  • Healthcare Value Capital's portfolio value rose 13% quarter-over-quarter to $68.1M.

Based on Healthcare Value Capital's 13F filing for Q1 2016, filed 16 May 2016.